In 2026, the global perspective on Modafinil has evolved from viewing it simply as a "stay-awake pill" to recognizing it as a highly specific eugeroic with unique neuroprotective qualities. Unlike the generic stimulants of the past, Modafinil is now at the center of "Functional Connectivity" research, with 2026 studies highlighting its ability to synchronize the communication between the prefrontal cortex and the cerebellum—the areas of the brain responsible for complex planning and motor coordination.